Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 2 28-2, 2003, Pages

  Moore, Bethany B ^a,d   Peters Golden, Marc ^a   Christensen, Paul J ^a,b   Lama, Vibha ^a   Kuziel, William A ^c   Paine III, Robert ^a,b   Toews, Galen B ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c The University of Texas at Austin   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CC chemokine receptor 2; Chemokines; Lipid mediators; Lung; Monocyte chemoattractant protein 1

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FIBROGENESIS; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; METABOLIC INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN PROTEIN INTERACTION;

EID: 0037309390     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00168.2002     Document Type: Article

References (32)

1. Bitterman P, Wewers N, Rennard S, Adelberg S, and Crystal R. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest 77: 700-708, 1986.
2. Borok Z, Gillissen A, Buhl R, Hoyt R, Hubbard R, Ozaki T, Rennard S, and Crystal R. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis 144: 1080-1084, 1991.
3. Chauncey J, Peters-Golden M, and Simon R. Arachidonic acid metabolism by rat alveolar epithelial cells. Lab Invest 58: 133-140, 1988.
4. Christensen P, Goodman R, Pastoriza L, Moore B, and Toews G. Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell dependent. Am J Pathol 155: 1773-1779, 1999.
5. Corti M, Brody A, and Harrison J. Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol 14: 309-315, 1996.
6. Elias J. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via prostagland-independent and independent mechanisms. Am Rev Respir Dis 138: 652-658, 1988.
7. Goldstein R and Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 257: 8630-8633, 1982.
8. Haschek WM and Witschi H. Pulmonary fibrosis - a possible mechanism. Toxicol Appl Pharmacol 51: 475-487, 1979.
9. Katzenstein A and Myers J. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 157: 1301-1315, 1998.
10. Keogh B and Crystal R. Alveolitis: the key to the interstitial lung disorders. Thorax 37: 1-10, 1982.
11. Klien JH and Adamson IY. Fibroblast inhibition and prostaglandin secretion by alveolar epithelial cells exposed to silica. Lab Invest 60: 808-813, 1989.
12. Korn J, Halushka P, and Leroy E. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest 65: 543-554, 1980.
13. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, and Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94: 12053-12058, 1997.
14. Lama V, Moore B, Christensen P, Toews G, and Peters-Golden M. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2 dependent. Am J Respir Cell Mol Biol 27: 752-758, 2002.
15. Leslie CC, McCormick-Shannon K, Mason RJ, and Shannon JM. Proliferation of rat alveolar epithelial cells in low density primary culture. Am J Respir Cell Mol Biol 9: 64-72, 1993.
16. Mannino D, Etzel R, and Parrish R. Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med 153: 1548-1552, 1996.
17. Mapel D, Samet J, and Coultas D. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. Chest 110: 1058-1067, 1996.
18. Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, McDonald R, Phare SM, Peters-Golden M, Paine R III, and Toews GB. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol 165: 4032-4039, 2000.
19. Moore BB, Paine R III, Christensen PJ, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, and Toews GB. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167: 4368-4377, 2001.
20. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
21. Ozaki T, Moriguchi H, Nakamura Y, Kamei T, Yasuoka S, and Ogura T. Regulatory effect of prostaglandin E2 on fibronectin release from human alveolar macrophages. Am Rev Respir Dis 141: 965-969, 1990.
22. Paine R III, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, and Strieter RM. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 150: 4561-4570, 1993.
23. Pan T, Mason R, Westcott J, and Shannon J. Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 25: 353-361, 2001.
24. Peters-Golden M, McNish R, Hyzy R, Shelly C, and Toews G. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol 144: 263-270, 1989.
25. Selman M, King TE, and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151, 2001.
26. Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 106: 37S-42S, 1999.
27. Smith W and Marnett L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1083: 1-17, 1991.
28. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, and Strieter RM. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem 266: 9912-9918 1991.
29. Terzaghi M, Nettesheim P, and Williams ML. Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Res 38: 4546-4553, 1978.
30. Ward P and Hunninghake G. Lung inflammation and fibrosis. Am J Respir Crit Care Med 157: S123-S129, 1998.
31. Witschi IH. Proliferation of type II alveolar cells: a review of common responses in toxic lung injury. Toxicology 5: 267-277, 1976.
32. Young L and Adamson IY. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ Health Perspect 101: 56-61, 1993.